Make the Investmentcase: Why shouldpeople invest in yourstock?
TABLE OF CONTENTSINTRODUCTION...........................................................................................................................1INVESTEMENT CASE..................................................................................................................1THE SECOTOR OUTLOOK..........................................................................................................1Top-down approach.....................................................................................................................3FUNDAMENTAL ANALYSIS......................................................................................................4RISK ANALYSIS...........................................................................................................................8SWOT..........................................................................................................................................8CONCLUSION................................................................................................................................9REFERENCES..............................................................................................................................10
INTRODUCTIONInvestment decision have been made by an individual which is based on their analysis overthe market value and overall performance of the organisation in the market segmentations.Therefore, investors articulate the overall performance of industry by analysing its pasts records.Thus, such analysis will be adequate and helpful in making proper ascertainment of the database. In the present report there will be operational analysis made on GlaxoSmithKline forapproaching the investors in making investments in organisation. There will be study over theentire pharmaceutical industry with respect to demonstrate the growth and profitability of suchbusiness in the coming years.INVESTEMENT CASEInvesting in a pharmaceutical industry will be profitable for the investors as theseorganisations are rapidly growing in UK Market. GlaxoSmithKline have been denoted as the bestpharmaceutical industry in the world which have various branches throughout countries. It hasbeen analysed that the firm in rapidly growing in this sector with a motive to present the bestquality medicines among the buyers. The faith in this industry is relevant with the strength ofresearch and development department of the organisation is making efforts in testing the drugsand launching in the market (GlaxoSmithKline PLC, 2018). However, as per analysing thegrowth of share value of this industry which determines that there will be adequate raise inprofitability which will bring higher returns to the investors in the upcoming period.THE SECOTOR OUTLOOKIn respect with analysing the overall pharmaceutical sector on which it can be said that theseindustries are more productive in UK. The average turnover has been retained through suchsector is around 41.8 billion pounds which is facilitating the 8.2% of UK goods exporting toother nation. along with this there are raise in the number of employees in these sectors whichare around 113,000 of people have directly being employed and engaged in this business (Wuand et.al., 2017).There are various industries which are making efforts as well as retaining the higher marketgains in such as AstraZeneca as well as GlaxoSmithKline. This sector is heavily integrated withEU supply chain which presents relies on friction free transfer of material and ingredients. Thehigher utilisation of these industries has been made in research and development operationswhich have reflected in the fruitful gains improvement in the quality services.1
Figure 1 Growth of Pharmaceutical industries in UK(Source: Pharmaceutical industry drives British research and innovation, 2014)Interpretation: On the basis of above graphical presentation on which trading outcomesof pharmaceutical industries have been ascertained which reflects the earning and gains of thebusiness. Moreover, there have been comparison of UK’s pharmaceutical trade with EU’s tradebalance on which UK is retaining higher turnover than EU. Moreover, investing inpharmaceutical industries will be fruitful to the investors in terms of retaining profitable returnsover their invested funds in the industry. It has been expected here that, these industries willre4tain higher profitability will be helpful in uplifting the GDP which in turn improves theeconomic stability in the nation.2
Found this document preview useful?
Related Documents
Corporate Strategy Force - Pestle Analysislg...
|15
|4206
|31
Corporate Strategic Analysis - Assignmentlg...
|16
|4647
|93
Accounting and finance for managers | assignmentlg...
|31
|5889
|18
Equality and Diversity within the organisationlg...